Condensed Consolidated Income Statements - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Revenues [Abstract] | ||||
| Total revenue | $ 1,622,245 | $ 1,645,280 | $ 3,224,115 | $ 3,142,514 |
| Expenses: | ||||
| Salaries and benefits | 676,186 | 671,697 | 1,337,617 | 1,329,349 |
| Professional fees | 327,843 | 297,012 | 644,913 | 577,869 |
| Supplies | 279,621 | 270,639 | 548,174 | 529,494 |
| Other operating expenses | 174,838 | 163,698 | 339,989 | 294,465 |
| Interest expense | 12,569 | 14,729 | 24,780 | 28,905 |
| Depreciation and amortization | 41,342 | 39,309 | 84,328 | 75,510 |
| Other non-operating losses (gains) | 0 | 560 | (5,890) | (20,723) |
| Total operating expenses | 1,579,042 | 1,523,288 | 3,106,321 | 2,946,324 |
| Income before income taxes | 43,203 | 121,992 | 117,794 | 196,190 |
| Income tax expense | 8,514 | 26,291 | 24,617 | 41,524 |
| Net income | 34,689 | 95,701 | 93,177 | 154,666 |
| Net income attributable to noncontrolling interests | 17,790 | 22,751 | 36,428 | 40,333 |
| Net income attributable to Ardent Health, Inc. | $ 16,899 | $ 72,950 | $ 56,749 | $ 114,333 |
| Net income per share: | ||||
| Basic (in USD per share) | $ 0.12 | $ 0.52 | $ 0.40 | $ 0.82 |
| Diluted (in USD per share) | $ 0.12 | $ 0.52 | $ 0.40 | $ 0.81 |
| Weighted-average common shares outstanding: | ||||
| Basic (in shares) | 141,688,279 | 140,374,892 | 141,478,312 | 140,219,452 |
| Diluted (in shares) | 143,052,519 | 141,517,661 | 142,414,946 | 141,111,732 |
| Nonrelated Party | ||||
| Expenses: | ||||
| Rents and leases | $ 27,957 | $ 27,825 | $ 55,038 | $ 55,586 |
| Related Party | ||||
| Expenses: | ||||
| Rents and leases | $ 38,686 | $ 37,819 | $ 77,372 | $ 75,869 |
| X | ||||||||||
- Definition Amount of expense for allocation of cost of tangible and intangible assets over their useful lives, and reduction in quantity of natural resource due to consumption directly used in production of good and rendering of service. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of gains or losses resulting from nonoperating activities (for example, interest and dividend revenue, property, plant and equipment impairment loss, and so forth). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of operating lease expense. Excludes sublease income. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense associated with supplies that were used during the current accounting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|